Capital International’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-82,588
Closed -$3.43M 160
2023
Q2
$3.43M Sell
82,588
-18,239
-18% -$757K 0.19% 116
2023
Q1
$6.06M Buy
100,827
+14,979
+17% +$901K 0.36% 85
2022
Q4
$6.3M Sell
85,848
-1,055
-1% -$77.4K 0.43% 77
2022
Q3
$6.6M Sell
86,903
-5,329
-6% -$405K 0.46% 70
2022
Q2
$6.41M Sell
92,232
-14,670
-14% -$1.02M 0.48% 70
2022
Q1
$8.86M Buy
106,902
+8,362
+8% +$693K 0.5% 67
2021
Q4
$7.4M Buy
98,540
+12,624
+15% +$948K 0.38% 76
2021
Q3
$9.98M Buy
85,916
+3,815
+5% +$443K 0.54% 52
2021
Q2
$18.2M Buy
82,101
+20,272
+33% +$4.5M 1% 22
2021
Q1
$8.17M Buy
61,829
+2,211
+4% +$292K 0.49% 57
2020
Q4
$10.3M Buy
59,618
+824
+1% +$143K 0.6% 49
2020
Q3
$6.54M Buy
58,794
+32,572
+124% +$3.63M 0.44% 61
2020
Q2
$1.56M Hold
26,222
0.15% 116
2020
Q1
$1.77M Buy
+26,222
New +$1.77M 0.2% 108